BioNTech SE (BNTX)
100.60
+1.85
(+1.87%)
USD |
NASDAQ |
May 31, 16:00
100.51
-0.09
(-0.09%)
After-Hours: 20:00
BioNTech Revenue (Annual): 4.134B for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 4.134B |
December 31, 2022 | 18.26B |
December 31, 2021 | 22.45B |
December 31, 2020 | 550.80M |
Date | Value |
---|---|
December 31, 2019 | 121.58M |
December 31, 2018 | 150.64M |
December 31, 2017 | 69.76M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
121.58M
Minimum
2019
22.45B
Maximum
2021
9.103B
Average
4.134B
Median
2023
Revenue (Annual) Benchmarks
Pfizer Inc | 58.50B |
Moderna Inc | 6.754B |
GSK PLC | 37.74B |
NuCana PLC | -- |
Autolus Therapeutics PLC | 1.698M |